
July 2003
A little known fund investing in biotechnology shares has outperformed the "Big Boys" of fund management this year. QUINN-life's biotechnology fund is the highest performing fund this year, producing 32% up to last Friday.
The Quinn fund buys a basket of 20 biotechnology stocks and the performance will follow closely that of the Nasdaq Biotechnology Index. This is a cheap way to get into the shares markets because they are not managed.

QUINN Insurance Limited and QUINN-life direct Limited are regulated by the Irish Financial Regulator.
QUINN-life direct Limited is a private company limited by shares. All Rights Reserved. Copyright Quinn Group